Breaking News

WuXi Biologics Advances Cell Culture Productivity

WuXiUP technology enables 1,000L disposable bioreactors to achieve comparable productivity as traditional 10,000-20,000L stainless bioreactors

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi Biologics has advanced cell culture productivity for an Fc-fusion protein. The cell culture has a productivity of 2.5g/L/day and 51g/L bioreactor volume in a 20-day continuous cell culture process called WuXiUP (Ultra-high Productivity). According to the company, this is more than 10 times productivity of 3-5g/L of traditional fed-batch process. This technology is being scaled up to GMP production and will be deployed throughout WuXi Biologics’ global manufacturing network in China, I...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters